Michael Vi / Shutterstock.com
US biotechnology company 10x Genomics is to pay its competitor, Becton Dickinson, $25 million as part of a deal to end worldwide patent infringement litigation between the companies.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
10x Genomics, Becton Dickinson, patent litigation, settlement agreement, cell analysis, biotechnology, US Securities and Exchange Commission
